← Back to Search

Multivitamin-mineral supplement

Prenatal Multivitamins for Pregnancy

N/A

Recruiting

Research Sponsored by City University of New York

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Pregnant women over 18 years of age

Be older than 18 years old

Must not have

Diabetes prior to and during pregnancy

Liver disease prior to and during pregnancy

Timeline

Screening 3 weeks

Treatment Varies

Follow Up after 24 weeks of intervention

Awards & highlights

No Placebo-Only Group

Summary

This trial tests if a prenatal multivitamin/multimineral supplement can improve nutrition status in pregnant women and their babies.

Who is the study for?

This trial is for pregnant women over 18 with a single baby, who are not dealing with diabetes, heart conditions, or liver disease before or during pregnancy. It's designed to help those interested in optimizing their nutrition and the health of their unborn child.

What is being tested?

The study compares two prenatal multivitamins: Ritual Epre Multivitamin-mineral supplement and a control MVI. Participants will be randomly assigned to one of these groups and take the supplements throughout their pregnancy to see which leads to better maternal-fetal nutrition.

What are the potential side effects?

Since both MVIs are commercially available and over-the-counter, side effects should be minimal but may include typical reactions such as nausea or digestive discomfort that some experience from taking vitamins.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am pregnant and over 18 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have had diabetes before and during my pregnancy.

Select...

I have had liver disease before and during my pregnancy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ after 24 weeks of intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~after 24 weeks of intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and after 24 weeks of intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Biotin status

Folate status

placental functional gene expression regulation

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Ritual EpreExperimental Treatment1 Intervention

This group will receive 2 Ritual Epre multivitamin-mineral supplement pills daily.

Group II: Control MVIActive Control1 Intervention

For the prenatal arm, this group will receive a control multivitamin-mineral supplement pill and a 200 mg docosahexaenoic acid (DHA) pill that are commercially available.

0 / 3Eligibility criteria met